Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant

MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has been...

Related Keywords

Australia ,Japan ,Melbourne ,Victoria ,United States ,Canada ,Switzerland ,Belgium ,Australian ,Kristofer Thurecht ,Kyahn Williamson ,Michael Wheatcroft ,Telix Pharmaceuticals ,Linkedin ,University Of Queensland ,Research Hub ,Drug Administration ,Australian Research Council ,Australian Securities Exchange ,Industrial Transformation Research Program ,Australian Therapeutic Goods Administration ,Australian Institute For ,Corporate Communications ,Telix Pharmaceuticals Limited ,Advanced Manufacture ,Targeted Radiopharmaceuticals ,Chief Scientist ,Australian Institute ,Professor Kristofer Thurecht ,Hub Director ,Molecularly Targeted Radiation ,